These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 8274455

  • 1. Functional interaction of wild-type and mutant p53 transfected into human tumor cell lines carrying activated ras genes.
    Sharma S, Schwarte-Waldhoff I, Oberhuber H, Schäfer R.
    Cell Growth Differ; 1993 Oct; 4(10):861-9. PubMed ID: 8274455
    [Abstract] [Full Text] [Related]

  • 2. Wild-type p53 induces apoptosis in a Burkitt lymphoma (BL) line that carries mutant p53.
    Ramqvist T, Magnusson KP, Wang Y, Szekely L, Klein G, Wiman KG.
    Oncogene; 1993 Jun; 8(6):1495-500. PubMed ID: 8502475
    [Abstract] [Full Text] [Related]

  • 3. Dominance of wild-type p53-mediated transcriptional activation in breast epithelial cells.
    Davis P, Bazar K, Huper G, Lozano G, Marks J, Iglehart JD.
    Oncogene; 1996 Sep 19; 13(6):1315-22. PubMed ID: 8808706
    [Abstract] [Full Text] [Related]

  • 4. Nuclear localization is essential for the activity of p53 protein.
    Shaulsky G, Goldfinger N, Tosky MS, Levine AJ, Rotter V.
    Oncogene; 1991 Nov 19; 6(11):2055-65. PubMed ID: 1719467
    [Abstract] [Full Text] [Related]

  • 5. p53 dependence and apoptosis in response to FP treatment with p53-transfected colon cancer cell lines by use of thin layer collagen gel.
    Matsuhashi N, Saio M, Matsuo A, Sugiyama Y, Saji S.
    Oncol Rep; 2004 Aug 19; 12(2):357-61. PubMed ID: 15254702
    [Abstract] [Full Text] [Related]

  • 6. [Effects of exogenous wild type p53 on malignant growth of human lung cancer cell line].
    Wang H, Lai B, Li J.
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 May 19; 21(5):268-72. PubMed ID: 11326947
    [Abstract] [Full Text] [Related]

  • 7. Involvement of the tumor suppressor gene p53 in tumor necrosis factor-induced differentiation of the leukemic cell line K562.
    Ehinger M, Nilsson E, Persson AM, Olsson I, Gullberg U.
    Cell Growth Differ; 1995 Jan 19; 6(1):9-17. PubMed ID: 7718488
    [Abstract] [Full Text] [Related]

  • 8. Effects of adenoviral wild-type p53 gene transfer in p53-mutated lymphoma cells.
    Buttgereit P, Schakowski F, Märten A, Brand K, Renoth S, Ziske C, Schöttker B, Ebert O, Schroers R, Schmidt-Wolf IG.
    Cancer Gene Ther; 2001 Jun 19; 8(6):430-9. PubMed ID: 11498763
    [Abstract] [Full Text] [Related]

  • 9. Wild-type p53 suppresses growth of human prostate cancer cells containing mutant p53 alleles.
    Isaacs WB, Carter BS, Ewing CM.
    Cancer Res; 1991 Sep 01; 51(17):4716-20. PubMed ID: 1873816
    [Abstract] [Full Text] [Related]

  • 10. Tumor and growth suppression of breast cancer cells by chromosome 17-associated functions.
    Negrini M, Sabbioni S, Haldar S, Possati L, Castagnoli A, Corallini A, Barbanti-Brodano G, Croce CM.
    Cancer Res; 1994 Apr 01; 54(7):1818-24. PubMed ID: 8137297
    [Abstract] [Full Text] [Related]

  • 11. The properties of p53 proteins selected for the loss of suppression of transformation.
    Olson DC, Levine AJ.
    Cell Growth Differ; 1994 Jan 01; 5(1):61-71. PubMed ID: 8123594
    [Abstract] [Full Text] [Related]

  • 12. Adenovirus-mediated p53 gene transfer inhibits growth of human tumor cells expressing mutant p53 protein.
    Harris MP, Sutjipto S, Wills KN, Hancock W, Cornell D, Johnson DE, Gregory RJ, Shepard HM, Maneval DC.
    Cancer Gene Ther; 1996 Jan 01; 3(2):121-30. PubMed ID: 8729911
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Growth suppression of human breast cancer cells by the introduction of a wild-type p53 gene.
    Casey G, Lo-Hsueh M, Lopez ME, Vogelstein B, Stanbridge EJ.
    Oncogene; 1991 Oct 01; 6(10):1791-7. PubMed ID: 1923504
    [Abstract] [Full Text] [Related]

  • 16. Expression of wild-type p53 in human A673 cells suppresses tumorigenicity but not growth rate.
    Chen YM, Chen PL, Arnaiz N, Goodrich D, Lee WH.
    Oncogene; 1991 Oct 01; 6(10):1799-805. PubMed ID: 1923505
    [Abstract] [Full Text] [Related]

  • 17. Mutant human tumor suppressor p53 modulates the activation of mitogen-activated protein kinase and nuclear factor-kappaB, but not c-Jun N-terminal kinase and activated protein-1.
    Gulati AP, Yang YM, Harter D, Mukhopadhyay A, Aggarwal BB, Benzil DL, Whysner J, Albino AP, Murali R, Jhanwar-Uniyal M.
    Mol Carcinog; 2006 Jan 01; 45(1):26-37. PubMed ID: 16267831
    [Abstract] [Full Text] [Related]

  • 18. p53-dependent inhibition of progestin-induced VEGF expression in human breast cancer cells.
    Liang Y, Wu J, Stancel GM, Hyder SM.
    J Steroid Biochem Mol Biol; 2005 Feb 01; 93(2-5):173-82. PubMed ID: 15860260
    [Abstract] [Full Text] [Related]

  • 19. Growth suppression of normal mammary epithelial cells by wild-type p53.
    Merlo GR, Venesio T, Taverna D, Marte BM, Callahan R, Hynes NE.
    Oncogene; 1994 Feb 01; 9(2):443-53. PubMed ID: 8290256
    [Abstract] [Full Text] [Related]

  • 20. Analysis of the tumorigenicity of the X gene of hepatitis B virus in a nontransformed hepatocyte cell line and the effects of cotransfection with a murine p53 mutant equivalent to human codon 249.
    Oguey D, Dumenco LL, Pierce RH, Fausto N.
    Hepatology; 1996 Nov 01; 24(5):1024-33. PubMed ID: 8903370
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.